Biotech

All Articles

Boehringer offers up to $1.3 B for checkpoint prevention biotech

.Boehringer Ingelheim is providing to $1.3 billion for Nerio Therapies as well as a preclinical invu...

Ventyx's last resort for inflammatory med ends in Crohn's failing

.Ventyx Biosciences' Crohn's health condition medication carried out not help individuals accomplish...

Cognition's stage 2 sparkle records taint Alzheimer's possibility

.Cognition Rehabs' period 2 SHINE test has taken a few of the luster off the Alzheimer's disease med...

BMS axes bispecific months after filing to operate period 3 trial

.Bristol Myers Squibb has had a whiplash change of heart on its own BCMA bispecific T-cell engager, ...

Charles Baum manages Terremoto as CEO

.Charles Baum, M.D., Ph.D., who managed Mirati Rehabs' $ 5.8 billion sale to Bristol Myers Squibb in...

Asarina to shut after efforts to partner Tourette's drug fail

.After communicating to greater than 200 business to partner a Tourette syndrome therapy that showed...

Novartis pens $150M upfront bispecifics handle Dren Bio

.Novartis has possessed some rotten luck with bispecific antitoxins before, however evaluating due t...

AstraZeneca plants an EGFR plant along with Pinetree offer worth $45M

.Pinetree Therapeutics are going to help AstraZeneca plant some plants in its pipe along with a bran...

GRO rounds up $60M collection B to take gout pain treatment into clinic

.GRO Biosciences has ended the week with an added $60.3 million in the bank, which the protein thera...

Chutes &amp Ladders-- Gilead's Merdad Parsey goes, Cassava drops CEO

.Welcome to this week's Chutes &amp Ladders, our roundup of considerable leadership hirings, firings...